In this episode of SciBud, join host Rowan as we unravel an intriguing discovery in the world of cancer research, focusing on the interaction between PD-1 and AXL in osteosarcoma, the most prevalent bone cancer affecting children and young adults. Despite advancements in treatment, outcomes for metastatic osteosarcoma remain challenging, prompting researchers to explore the complex role of the PD-1 immune checkpoint. Through a series of sophisticated experiments, including western blotting and mass spectrometry, scientists identified a robust interaction between PD-1 and AXL, revealing that this connection is conserved not only in humans but also in canine osteosarcoma—a promising avenue for future therapies. While the study showcases rigorous methods, it also highlights areas for improvement in data accessibility. Tune in as we break down these critical findings and their implications for advancing cancer treatment, all while keeping the conversation engaging and accessible for listeners of all backgrounds! Link to episode page with article citation: www.scibud.media/podcast/season/2024/episode/3